(12) United States Patent (10) Patent No.: US 8,642,801 B2 Kong Et Al
Total Page:16
File Type:pdf, Size:1020Kb
USOO86428O1B2 (12) United States Patent (10) Patent No.: US 8,642,801 B2 Kong et al. (45) Date of Patent: Feb. 4, 2014 (54) METHODS AND COMPOSITIONS FOR 4,528, 184 A 7, 1985 Kurono et al. TREATING AMYLOID-RELATED DISEASES 4,540,564 A 9, 1985 Bodor 4,563,470 A 1/1986 Durlach 4,593,045 A 6, 1986 Flork et al. (75) Inventors: Xianqi Kong, Dollard-des-Ormeaux 4,713,376 A 12/1987 Kuzuya et al. (CA); David Migneault, Laval (CA); 4,737,353 A 4, 1988 Flanigen et al. Isabelle Valade, Laval (CA); Xinfu Wu, 4,737,357 A 4, 1988 Lehmann et al. 4,812,512 A 3, 1989 Buendia et al. Laval (CA); Francine Gervais, Ile 4,847,082 A 7, 1989 Sabin Bizard (CA) 4.956,347 A 9, 1990 Ban et al. 5,017,566 A 5, 1991 Bodor (73) Assignee: BHI Limited Partnership, Laval, 5,023,252 A 6, 1991 HSeih Quebec (CA) 5,024,998 A 6, 1991 Bodor 5,039,794. A 8, 1991 Wier et al. Notice: Subject to any disclaimer, the term of this 5,064,923 A 11/1991 Kashihara et al. (*) 5, 112,863. A 5/1992 Hashimoto et al. patent is extended or adjusted under 35 5,124,146 A 6/1992 Neuwelt U.S.C. 154(b) by 190 days. 5,153,179 A 10, 1992 Eb1 5,164,295 A 1 1/1992 Kisilevsky et al. (21) Appl. No.: 12/613,412 5,166.320 A 11/1992 Wu et al. 5,177,064 A 1/1993 Bodor Filed: Nov. 5, 2009 5, 192,753 A 3, 1993 McGeer et al. (22) 5,194,654 A 3, 1993 Hostetler et al. 5,223,510 A 6/1993 Gubinet al. (65) Prior Publication Data 5,242.932 A 9/1993 Gandy et al. 5,254,342 A 10, 1993 Shen et al. US 2010/O113591 A1 May 6, 2010 5,258.402 A 1 1/1993 Maryanoff 5,270,312 A 12/1993 Glase et al. Related U.S. Application Data 5,276,059 A 1/1994 Caughey et al. 5,284,876 A 2, 1994 Shashoua et al. (63) Continuation of application No. 1 1/316,694, filed on 5,318,958 A 6/1994 Kisilevsky Dec. 21, 2005, now abandoned, which is a 5,342,977 A 8/1994 Baschang et al. continuation-in-part of application No. 10/871,514, 5,374,548 A 12/1994 Caras filed on Jun. 18, 2004, now Pat. No. 7,414,076. (Continued) (60) Provisional application No. 60/480,906, filed on Jun. FOREIGN PATENT DOCUMENTS 23, 2003, provisional application No. 60/512,047, filed on Oct. 17, 2003, provisional application No. CA 10953.06 A1 2, 1981 60/638,819, filed on Dec. 22, 2004. CA 2031433 A1 6, 1991 (Continued) (51) Int. C. C07C 309/19 (2006.01) OTHER PUBLICATIONS A6 IK3I/85 (2006.01) (52) U.S. C. Abderhalden et al. (CAPLUS Abstract of Fermentforschung (1930), USPC ............................................. 562/44; 514/576 12, 180-222).* Wermuth, The Practice of Medicinal Chemsitry, 2d ed. (2003), 768 (58) Field of Classification Search pages. Chapters 9-10 provided.* USPC ............................................. 562/44; 514/576 IUPAC. Compendium of Chemical Terminology, 2nded. (The “Gold See application file for complete search history. Book”). Compiled by A. D. McNaught and A. Wilkinson. Blackwell Scientific Publications, Oxford (1997). "Amino-acid residue” defi (56) References Cited nition provided.* Cerovsky et al., 1994, Int. J. Peptide & Protein Res., 44(5), 466-471. U.S. PATENT DOCUMENTS De Bont et al., 1996, Bioorg & Med. Chem. 6(24), 3035-3040. 2,376,911 A 5, 1945 Graenacher et al. Higashiura et al., 1992, J. Chem. Res., Synopsis, (8), 250-251. 2,531,468 A 1 1/1950 Reynolds et al. Hollowood, C.J., 2003, Org. & Biomolec. Chem., 1(10), 1664-1675. 3,218,352 A 11, 1965 Freifelder et al. 3,236,881 A 2f1966 Distler et al. (Continued) 3,453,309 A 7, 1969 Westland 3,580,936 A 5, 1971 Patchett et al. 3,658,966 A 4, 1972 Tsunoo et al. Primary Examiner — Robert Havlin 3,872,125 A 3, 1975 Houlihan et al. (74) Attorney, Agent, or Firm — McCarter & English, LLP: 3,920,833. A 11/1975 Cook et al. Danielle L. Herritt 4,085,134 A 4, 1978 Redmore et al. 4,187,245 A 2f1980 Redmore et al. 4,199,601 A 4, 1980 Durlach (57) ABSTRACT 4.255.448 A 3, 1981 Fariello 4,267,194 A 5, 1981 Durlach 4,271,189 A 6, 1981 Durlach Methods, compounds, pharmaceutical compositions and kits 4,355,043 A 10, 1982 Durlach are described for treating or preventing amyloid-related dis 4,386,081 A 5/1983 Helgstrand et al. CaSC. 4,448,779 A 5, 1984 Blanchard et al. 4,521,619 A 6/1985 Kaplan 4,522,811 A 6/1985 Eppstein et al. 17 Claims, No Drawings US 8,642.801 B2 Page 2 (56) References Cited 2005/0031651 A1 2/2005 Gervais et al. 2005, OO38000 A1 2/2005 Kong et al. U.S. PATENT DOCUMENTS 2005/0142191 A1 6/2005 Legore 2005/0215562 A1 9/2005 Tremblay et al. 5,383,988 A 1/1995 Herrmann et al. 2006, OO14752 A1 1/2006 Weaver et al. 5,385,915 A 1/1995 Buxbaum et al. 2006, O116347 A1 6/2006 Kisilevsky et al. 5,389,623 A 2, 1995 Bodor 2006/0135479 A1 6/2006 SZarek et al. 5,399,331 A 3/1995 Loughrey et al. 2006.01670.57 A1 7/2006 Kong et al. 5,405,834 A 4, 1995 Bundgaard et al. 2006.0167095 A1 7/2006 Kisilevsky et al. 5,413,996 A 5/1995 Bodor 2006/0183800 A1 8/2006 Kong et al. 5,416,016 A 5, 1995 Low et al. 2006/0223855 A1 10/2006 Kong et al. 5.430,052 A 7/1995 Higashiura et al. 2006/0252829 A1 11/2006 Garceau et al. 5.434,137 A 7/1995 Black 2007/0010573 A1 1/2007 Kong et al. 5,442,043 A 8/1995 Fukuta et al. 2007, OO15737 A1 1/2007 Clark et al. 5,463,092 A 10, 1995 Hostetler et al. 2007/0021483 A1 1/2007 Chalifour et al. 5,466,683 A 1 1/1995 Sterling et al. 2007/0078O82 A1 4/2007 Kisilevsky et al. 5,525,727 A 6/1996 Bodor 2007/0265334 A1 1 1/2007 Kisilevsky et al. 5,527,527 A 6, 1996 Friden 2008.0004244 A1 1/2008 SZarek et al. 5,622,934 A 4/1997 Fricket al. 2008, OO15180 A1 1/2008 Kong et al. 5,643,562 A 7/1997 Kisilevsky et al. 2008.OO27097 A1 1/2008 Kong et al. 5,668,117 A 9/1997 Shapiro 2008, OO38192 A1 2/2008 Gervais 5,672,683 A 9, 1997 Friden et al. 2010/O190753 A1 7/2010 Kong et al. 5,728,375 A 3/1998 Kisilevsky et al. 5,776,970 A 7, 1998 Shechter et al. FOREIGN PATENT DOCUMENTS 5,780,510 A 7/1998 Carney 5,840,294 A 1 1/1998 Kisilevsky et al. 5,858,326. A 1/1999 Kisilevsky et al. f 2.99. At 12: 5,952,389 A 9/1999 Fogel DE 4004978 A1 8, 1991 5,989,592 A 1 1/1999 Collin EP O 115657 A1 8/1984 6,015,835 A 1/2000 Miyamoto et al. EP O293974 A1 12/1988 6,024,977 A 2/2000 Yatvin et al. EP 0309421 A2 3, 1989 6,265,437 B1 7/2001 Berthelon et al. EP O405834 A2 1, 1991 6,310,073 B1 10/2001 Kisilevsky et al. EP O464759 A2 1/1992 6,376,557 B1 4/2002 Zaveri EP 1090 625 A2 4? 2001 6,440,952 B2 8/2002 Szarek et al. EP 1298 125 A1 4, 2003 6,670,399 B2 12/2003 Green et al. JP 60-184564 A 9, 1985 6,989.401 B2 1/2006 Maeda et al. JP 2-78620 3, 1990 7,153,692 B2 12/2006 Campbell et al. JP 2-149341. A 6, 1990 7.244.764 B2 7/2007 Kong et al. JP 04-077423. A 3, 1992 7.253,306 B2 8/2007 Kong et al. JP 04-103530 A 4, 1992 7,311,893 B2 12/2007 Gervais et al. WO WO-88.09171 A1 12, 1988 7.598,269 B2 10/2009 Kong et al. WO WO-90,09789 A2 9, 1990 2001/0048941 A1 12/2001 Kisilevsky et al. WO WO-91/04.014 A1 4, 1991 2002fOO94335 A1 7, 2002 Chalifour et al. WO WO-91/14434 A1 10, 1991 2002/0115717 A1 8/2002 Gervais et al. WO WO-91/14438 A1 10, 1991 2003/0077833 A1 4/2003 Campbell et al. WO WO-93/10459 A1 5.1993 2003. O153584 A1 8, 2003 Weaver et al. WO WO-94/OO135 A1 12, 1993 2003. O194375 A1 10, 2003 Weaver et al. WO WO-94f0111.6 A1 1, 1994 2004/0006092 A1 1/2004 Chalifour et al. WO WO-94.01131 A1 1, 1994 2004/0096453 A1 5/2004 Kisilevsky et al. WO WO-94f02178 A1 2, 1994 2004/0113277 A1 6, 2004 Chiras et al. WO WO-94,03424 A1 2, 1994 2004/O138178 A1 7/2004 SZarek et al. WO WO-94,06450 A1 3, 1994 2004/0208875 A1 10/2004 Kisilevsky et al. WO WO-94,22437 A2 10, 1994 2004/022O138 A1 11/2004 Gervais et al.